News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,929 Results
Type
Article (41403)
Company Profile (263)
Press Release (690249)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (204862)
Career Advice (2036)
Deals (35591)
Drug Delivery (131)
Drug Development (81544)
Employer Resources (173)
FDA (16518)
Job Trends (14987)
News (346882)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2599)
Accelerated approval (51)
Adcomms (27)
Allergies (173)
Alliances (49581)
ALS (213)
Alzheimer's disease (1805)
Antibody-drug conjugate (ADC) (472)
Approvals (16925)
Artificial intelligence (676)
Autoimmune disease (309)
Automation (57)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (199)
Brain cancer (73)
Breast cancer (771)
Cancer (5968)
Cardiovascular disease (483)
Career advice (1729)
Career pathing (43)
CAR-T (335)
CDC (57)
Celiac Disease (3)
Cell therapy (915)
Cervical cancer (49)
Clinical research (71010)
Collaboration (2091)
Company closure (5)
Compensation (1414)
Complete response letters (80)
COVID-19 (2747)
CRISPR (109)
C-suite (1155)
Cystic fibrosis (154)
Data (8136)
Decentralized trials (3)
Denatured (28)
Depression (163)
Dermatology (91)
Diabetes (599)
Diagnostics (6959)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (330)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (288)
Earnings (92157)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119930)
Executive appointments (1091)
FDA (20311)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1747)
Gene editing (236)
Generative AI (56)
Gene therapy (728)
GLP-1 (1060)
Government (4737)
Grass and pollen (6)
Guidances (411)
Healthcare (19086)
HIV (81)
Huntington's disease (56)
IgA nephropathy (101)
Immunology and inflammation (291)
Immuno-oncology (97)
Indications (197)
Infectious disease (3097)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (297)
Interviews (319)
IPO (16669)
IRA (50)
Job creations (3647)
Job search strategy (1433)
JPM (58)
Kidney cancer (19)
Labor market (104)
Layoffs (565)
Leadership (40)
Legal (7953)
Liver cancer (102)
Longevity (33)
Lung cancer (788)
Lymphoma (439)
Machine learning (60)
Management (59)
Manufacturing (1071)
MASH (199)
Medical device (13948)
Medtech (14080)
Mergers & acquisitions (20186)
Metabolic disorders (1533)
mRNA (213)
Multiple sclerosis (192)
NASH (17)
Neurodegenerative disease (429)
Neuropsychiatric disorders (106)
Neuroscience (3349)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4532)
Now hiring (79)
Obesity (711)
Opinion (289)
Ovarian cancer (229)
Pain (258)
Pancreatic cancer (312)
Parkinson's disease (373)
Partnered (33)
Patents (606)
Patient recruitment (691)
Peanut (62)
People (59661)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22141)
Phase 2 (31288)
Phase 3 (23266)
Pipeline (9060)
Policy (321)
Postmarket research (2569)
Preclinical (9428)
Press Release (64)
Prostate cancer (313)
Psychedelics (54)
Radiopharmaceuticals (333)
Rare diseases (1090)
Real estate (5972)
Recruiting (70)
Regulatory (25501)
Reports (56)
Research institute (2416)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (179)
Series A (291)
Series B (214)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3643)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (63)
Vaccines (1110)
Venture capital (111)
Weight loss (455)
Women's health (128)
Worklife (20)
Date
Today (107)
Last 7 days (605)
Last 30 days (3382)
Last 365 days (30155)
2026 (13679)
2025 (30171)
2024 (35208)
2023 (40074)
2022 (51174)
2021 (55706)
2020 (54080)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31479)
2015 (37551)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (351)
Arkansas (14)
Asia (39747)
Australia (6519)
California (13519)
Canada (3827)
China (1380)
Colorado (574)
Connecticut (587)
Delaware (415)
Europe (86021)
Florida (2022)
Georgia (434)
Hawaii (3)
Idaho (63)
Illinois (1077)
India (92)
Indiana (611)
Iowa (23)
Japan (554)
Kansas (131)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1614)
Massachusetts (9641)
Michigan (370)
Minnesota (729)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3543)
New Mexico (29)
New York (3533)
North Carolina (1712)
North Dakota (9)
Northern California (6806)
Ohio (404)
Oklahoma (23)
Oregon (41)
Pennsylvania (2711)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5334)
Tennessee (215)
Texas (2151)
United States (47625)
Utah (402)
Vermont (1)
Virginia (324)
Washington D.C. (81)
Washington State (1080)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
731,929 Results for "cytomed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
November 19, 2025
·
5 min read
Press Releases
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
October 15, 2025
·
5 min read
Press Releases
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
November 7, 2025
·
5 min read
Press Releases
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
December 8, 2025
·
5 min read
Press Releases
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia
October 2, 2025
·
4 min read
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
CytoMed Therapeutics Limited has obtained board approval to launch, subject to certain terms and conditions, a pilot program to isolate and cryo-store peripheral blood mononuclear cells for and as a reward to loyal shareholders of CytoMed on a complimentary basis.
March 18, 2024
·
9 min read
Business
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
CytoMed Therapeutics Limited today announced that it has entered into a Heads of Agreement (HOA) with CytoMed Therapeutics China Limited company incorporated in Hong Kong and a Memorandum of Understanding (MOU) with BioNex Solutions Inc.
December 5, 2023
·
6 min read
Press Releases
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
October 3, 2024
·
5 min read
Press Releases
CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
April 28, 2025
·
12 min read
Business
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
CytoMed Therapeutics Limited today announced its first half of 2023 financial results and provided clinical and corporate updates.
November 17, 2023
·
5 min read
1 of 73,193
Next
